0001604586-23-000004.txt : 20230117
0001604586-23-000004.hdr.sgml : 20230117
20230117170214
ACCESSION NUMBER: 0001604586-23-000004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230117
DATE AS OF CHANGE: 20230117
EFFECTIVENESS DATE: 20230117
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RxRevu, Inc.
CENTRAL INDEX KEY: 0001604586
IRS NUMBER: 463578999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-470936
FILM NUMBER: 23532129
BUSINESS ADDRESS:
STREET 1: 2601 BLAKE STREET, SUITE 450
CITY: DENVER
STATE: CO
ZIP: 80205
BUSINESS PHONE: 800-360-4965
MAIL ADDRESS:
STREET 1: 2601 BLAKE STREET, SUITE 450
CITY: DENVER
STATE: CO
ZIP: 80205
D
1
primary_doc.xml
X0708
D
LIVE
0001604586
RxRevu, Inc.
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
800-360-4965
DELAWARE
None
None
Corporation
true
Steve
Lindseth
3001 Brighton Blvd., Suite 103
Denver
CO
COLORADO
80216
Executive Officer
Director
Kyle
Kiser
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Executive Officer
Director
Aaron
Cornell
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Executive Officer
Toby
Cosgrove
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Andrew
Firlik
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Daniel
Galles
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Albert
Prast
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Stephen
McHale
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Richard
Zane
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Director
Benton
Barney
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Executive Officer
Christie
Callahan
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Executive Officer
Lew
Parker
3001 Brighton Blvd., Suite 103
DENVER
CO
COLORADO
80216
Executive Officer
Other Health Care
Decline to Disclose
- 06b
false
2022-12-30
false
true
false
0
10000000
6000000
4000000
false
1
0
0
0
false
RxRevu, Inc.
/s/ Kyle Kiser
Kyle Kiser
Chief Executive Officer
2023-01-17